======= EIF3L =======
== Gene Information ==
* **Official Symbol**: EIF3L
* **Official Name**: eukaryotic translation initiation factor 3 subunit L
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=51386|51386]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y262|Q9Y262]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=EIF3L&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EIF3L|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/619197|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis (PubMed:17581632, PubMed:25849773, PubMed:27462815). The eIF-3 complex associates with the 40S ribosome and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-tRNAi and eIF-5 to form the 43S pre- initiation complex (43S PIC). The eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning of the mRNA for AUG recognition. The eIF-3 complex is also required for disassembly and recycling of post-termination ribosomal complexes and subsequently prevents premature joining of the 40S and 60S ribosomal subunits prior to initiation (PubMed:17581632). The eIF- 3 complex specifically targets and initiates translation of a subset of mRNAs involved in cell proliferation, including cell cycling, differentiation and apoptosis, and uses different modes of RNA stem-loop binding to exert either translational activation or repression (PubMed:25849773). {ECO:0000255|HAMAP-Rule:MF_03011, ECO:0000269|PubMed:17581632, ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.
|Paf67|
|viral translational termination-reinitiation|
|viral translation|
|eukaryotic 48S preinitiation complex|
|formation of cytoplasmic translation initiation complex|
|eukaryotic translation initiation factor 3 complex|
|eukaryotic 43S preinitiation complex|
|cytoplasmic translational initiation|
|translation initiation factor activity|
|cytoplasmic translation|
|viral gene expression|
|translational initiation|
|ribonucleoprotein complex assembly|
|ribonucleoprotein complex subunit organization|
|translation|
|peptide biosynthetic process|
|ribonucleoprotein complex biogenesis|
|amide biosynthetic process|
|peptide metabolic process|
|viral process|
|symbiotic process|
|cellular amide metabolic process|
|interspecies interaction between organisms|
|cellular protein-containing complex assembly|
|RNA binding|
|organonitrogen compound biosynthetic process|
|protein-containing complex assembly|
|cellular nitrogen compound biosynthetic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|protein-containing complex subunit organization|
|membrane|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp515|PU-H71 1μM R08 exp515]]|-2.65|
|[[:results:exp134|MS023 2μM R03 exp134]]|-2.59|
|[[:results:exp67|BVD-523 15μM R02 exp67]]|-2.22|
|[[:results:exp443|SNS-032 15μM R08 exp443]]|-2.18|
|[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|-2.04|
|[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.94|
|[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-1.85|
|[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.73|
|[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.73|
|[[:results:exp521|Salinomycin 3.5μM R08 exp521]]|-1.73|
|[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|-1.7|
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|1.74|
|[[:results:exp231|Epothilone-B 0.0015μM R05 exp231]]|1.82|
|[[:results:exp365|I-BRD9 4μM R07 exp365]]|2.03|
|[[:results:exp36|TRAIL 50ng/ml R00 exp36]]|2.13|
^Gene^Correlation^
|[[:human genes:e:eif3k|EIF3K]]|0.657|
|[[:human genes:a:atp13a1|ATP13A1]]|0.488|
|[[:human genes:b:bcl2l1|BCL2L1]]|0.467|
|[[:human genes:s:smg7|SMG7]]|0.412|
Global Fraction of Cell Lines Where Essential: 7/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|1/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|1/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|1/16|
|ovary|0/26|
|pancreas|1/24|
|peripheral nervous system|0/16|
|plasma cell|2/15|
|prostate|0/1|
|skin|1/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 2154
* **Expression level (log2 read counts)**: 8.13
{{:chemogenomics:nalm6 dist.png?nolink |}}